keyword
MENU ▼
Read by QxMD icon Read
search

DTC

keyword
https://www.readbyqxmd.com/read/29455653/novel-targeted-therapies-and-immunotherapy-for-advanced-thyroid-cancers
#1
REVIEW
George E Naoum, Michael Morkos, Brian Kim, Waleed Arafat
Thyroid cancer is a frequently encountered endocrine malignancy. Despite the favorable prognosis of this disease, 15-20% of differentiated thyroid cancer (DTC) cases and most anaplastic types, remain resistant to standard treatment options, including radioactive iodine (RAI). In addition, around 30% of medullary thyroid cancer (MTC) cases show resistance after surgery. The evolving understanding of disease-specific molecular therapeutic targets has led to the approval of two targeted therapies (Sorafenib and Lenvatinib) for RAI refractory DTC and another two drugs (Vandetanib and Cabozantinib) for MTC...
February 19, 2018: Molecular Cancer
https://www.readbyqxmd.com/read/29448931/effects-of-different-extracts-of-curcumin-on-tpc1-papillary-thyroid-cancer-cell-line
#2
Angelica Perna, Antonio De Luca, Laura Adelfi, Tammaro Pasquale, Bruno Varriale, Teresa Esposito
BACKGROUND: The thyroid gland is one of the largest endocrine glands in the body. The vast majority of TCs (> 90%) originate from follicular cells and are defined as differentiated thyroid cancers (DTC) and the two histological subtypes are the papillary TC with its variants and the follicular TC. Curcumin possesses a wide variety of biological functions, and thanks to its properties, it has gained considerable attention due to its profound medicinal values (Prasad, Gupta, Tyagi, and Aggarwal, Biotechnol Adv 32:1053-1064, 2014)...
February 15, 2018: BMC Complementary and Alternative Medicine
https://www.readbyqxmd.com/read/29445865/risk-of-recurrence-in-a-homogeneously-managed-pt3-differentiated-thyroid-carcinoma-population
#3
Nathalie Chereau, Etienne Dauzier, Gaëlle Godiris-Petit, Séverine Noullet, Isabelle Brocheriou, Laurence Leenhardt, Camille Buffet, Fabrice Menegaux
BACKGROUND: International guidelines for the management of differentiated thyroid cancers are based on the 7th TNM classification: pT3 tumors are defined as differentiated thyroid cancers (DTCs) measuring more than 4 cm in their greatest dimension that are limited to the thyroid or any tumor with minimal extrathyroidal extension (ETE; sternothyroid muscle or perithyroid soft tissues). Differences in clinicohistological features and prognosis among patients with pT3 tumors remain controversial, and studies regarding pT3 subgroups are lacking...
February 14, 2018: Langenbeck's Archives of Surgery
https://www.readbyqxmd.com/read/29436661/transdifferentiation-of-type-ii-alveolar-epithelial-cells-induces-reactivation-of-dormant-tumor-cells-by-enhancing-tgf-%C3%AE-1-snai2-signaling
#4
Yuanhong Zhou, Qiang Liu, Xiangchen Dai, Yuling Yan, Ying Yang, Hua Li, Xiaoling Zhou, Wenqi Gao, Xiaolan Li, Zuyang Xi
Dormant tumor cells (DTCs) serve a crucial role in the pathogenesis of metastasis and may compromise the efficacy of existing therapeutic modalities aimed at fully eradicating cancer. However, the mechanisms underlying the dormant-to-proliferating switch of DTCs remain largely unknown. The lung is one of the most common sites of metastatic recurrence. The transdifferentiation of alveolar epithelial cells II (AEC IIs) to AEC Is is a hallmark of alveolar epithelial stimulation. However, the role of AEC II transdifferentiation during the reactivation of DTCs has not been fully elucidated...
February 6, 2018: Oncology Reports
https://www.readbyqxmd.com/read/29429031/the-changing-multiple-sclerosis-treatment-landscape-impact-of-new-drugs-and-treatment-recommendations
#5
Irene Eriksson, Joris Komen, Fredrik Piehl, Rickard E Malmström, Björn Wettermark, Mia von Euler
PURPOSE: The purpose of this study is to describe the utilization of disease-modifying treatments (DMTs) in relapsing-remitting multiple sclerosis (MS) and assess the impact of both the introduction of new drugs and treatment recommendations (local recommendation on rituximab use issued at the largest MS clinic in Stockholm and regional Drug and Therapeutics Committee (DTC) recommendation on how dimethyl fumarate should be used). METHODS: Interrupted time series analyses using monthly data on all MS patients treated with DMTs in the Stockholm County, Sweden, from January 2011 to December 2017...
February 10, 2018: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/29419687/synchronous-papillary-thyroid-cancer-and-non-hodgkin-lymphoma-case-report
#6
Georgi I Popivanov, Pavel Bochev, Radka Hristoskova, Ventsislav M Mutafchiyski, Mihail Tabakov, Anthony Philipov, Roberto Cirocchi
RATIONALE: Differentiated thyroid cancer is the most common endocrine malignancy with concomitant hematological malignancy in 7%. PATIENT CONCERNS: We present a case of a synchronous papillary thyroid cancer and a follicular variant of non-Hodgkin lymphoma and discuss the possible diagnostic and treatment dilemmas. DIAGNOSIS: A 48-year-old female was reffered to our hospital with diagnosis "thyroid cancer". Due to a history compatable of synchronous lymphoproliferative disease we performed a computed tomography, which revealed multiple enlarged lymph nodes in the neck, mediastinum, axilla and abdomen...
February 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/29417654/prevalence-of-adverse-pathological-features-in-1-to-4%C3%A2-cm-low-risk-differentiated-thyroid-carcinoma
#7
Samskruthi P Murthy, Deepak Balasubramanian, Narayana Subramaniam, Gopalakrishnan Nair, Misha J C Babu, Priyank V Rathod, Krishnakumar Thankappan, Subramania Iyer, Smitha Nalumackal Vijayan, Chaya Prasad, Vasantha Nair
BACKGROUND: The American Thyroid Association (ATA) recommends thyroid lobectomy for 1 to 4 cm tumors without adverse features. We studied the prevalence of adverse pathological features in patients eligible for unilateral lobectomy. METHODS: We conducted a retrospective study of patients who underwent total thyroidectomy. Patients with differentiated thyroid cancer (DTC) with tumors measuring 1 to 4 cm with no known preoperative adverse features were included in this study...
February 8, 2018: Head & Neck
https://www.readbyqxmd.com/read/29417402/cost-effectiveness-of-routine-laryngoscopy-in-the-surgical-treatment-of-differentiated-thyroid-cancer
#8
Kyle Zanocco, David J Kaltman, James X Wu, Abbey Fingeret, Keith S Heller, James A Lee, Michael W Yeh, Julie Ann Sosa, Cord Sturgeon
BACKGROUND: Some surgeons perform flexible fiberoptic laryngoscopy (FFL) in all patients prior to thyroid cancer operations. Given the low likelihood of recurrent laryngeal nerve (RLN) or aerodigestive invasion in clinically low-risk thyroid cancers, the value of routine FFL in this group is controversial. We hypothesized that routine preoperative FFL would not be cost effective in low-risk differentiated thyroid cancer (DTC). METHODS: A decision model was constructed comparing preoperative FFL versus surgery without FFL in a clinical stage T2 N0 DTC patient without voice symptoms...
February 7, 2018: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29412384/thyroglobulin-levels-before-radioactive-iodine-therapy-and-dynamic-risk-stratification-after-1-year-in-patients-with-differentiated-thyroid-cancer
#9
Leonardo Bandeira, Rosália do Prado Padovani, Ana Luiza Ticly, Adriano Namo Cury, Nilza Maria Scalissi, Marília Martins Silveira Marone, Carolina Ferraz
OBJECTIVES: We sought to assess the relationship between stimulated thyroglobulin (sTg) before radioactive iodine therapy (RIT), and the dynamic risk stratification 1 year after treatment, and to establish the utility of the sTg as a predictor of response to therapy in these patients. A retrospective chart review of patients with differentiated thyroid cancer (DTC) who underwent RIT after surgery and were followed for at least 1 year, was carried out. SUBJECTS AND METHODS: Patients were classified according to the dynamic risk stratification 1 year after initial treatment...
December 2017: Archives of Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29410335/lung-cancer-specific-and-reduction-responsive-chimaeric-polymersomes-for-highly-efficient-loading-of-pemetrexed-and-targeted-suppression-of-lung-tumor-in-vivo
#10
Weijing Yang, Liang Yang, Yifeng Xia, Liang Cheng, Jian Zhang, Fenghua Meng, Jiandong Yuan, Zhiyuan Zhong
Lung cancer is one of the worldwide leading and fast-growing malignancies. Pemetrexed disodium (PEM, Alimta®), a small hydrophilic drug, is currently used for treating lung cancer patients. However, PEM suffers from issues like fast elimination, low bioavailability, poor tumor cell selectivity and penetration. Here, we report on lung cancer specific CSNIDARAC (CC9) peptide-functionalized reduction-responsive chimaeric polymersomes (CC9-RCPs) for efficient encapsulation and targeted delivery of PEM to H460 human lung cancer cells in vitro and in vivo...
February 2, 2018: Acta Biomaterialia
https://www.readbyqxmd.com/read/29402557/optimization-of-the-risk-benefit-ratio-of-differentiated-thyroid-cancer-treatment
#11
REVIEW
Hani Nasef, Iain J Nixon, Volkert Wreesmann
The vast majority of differentiated thyroid cancers (DTC) are characterized by an innocuous nature, excellent patient survival, and limited treatment requirement. However, a significant proportion of affected patients is prone to receiving overtreatment, due to undertreatment concerns associated with the difficulty to differentiate them from a small minority affected by aggressive DTC. Identification of prognostic factors and development of staging systems has helped to reduce the proportion of overtreatment in DTC...
January 31, 2018: European Journal of Surgical Oncology
https://www.readbyqxmd.com/read/29385592/communication-of-cancer-related-genetic-and-genomic-information-a-landscape-analysis-of-reviews
#12
Emily B Peterson, Wen-Ying Sylvia Chou, Anna Gaysynsky, Melinda Krakow, Ashley Elrick, Muin J Khoury, Kimberly A Kaphingst
Cancer-related genetic and genomic testing (CGT) is changing cancer care by personalizing care options, leading to an era of precision medicine. Advances in and increased use of CGT add complexity to clinical communication. This landscape analysis assessed published reviews of communication issues related to CGT and discusses implications for practice and behavioral research. A comprehensive electronic literature search was conducted of peer-reviewed literature reviews on studies related to CGT communication published between January 2010 and January 2017, resulting in a final sample of 24 reviews...
January 29, 2018: Translational Behavioral Medicine
https://www.readbyqxmd.com/read/29381585/clinico-social-factors-to-choose-radioactive-iodine-dose-in-differentiated-thyroid-cancer-patients-an-asian-survey
#13
Zeenat Jabin, Seong Young Kwon, Hee-Seung Bom, Yansong Lin, Ke Yang, Anri Inaki, Ayu Rosemeilia Dewi, Akram N Al-Ibraheem, Batool Al Balooshi, Teofilo O L San Luis
OBJECTIVE: This survey was designed to investigate the practice of radioactive iodine (RAI) therapy and clinico-social factors related to RAI dose in differentiated thyroid cancer (DTC) patients among Asian countries. MATERIALS AND METHODS: A survey questionnaire was mailed to Asian Nuclear Medicine physicians that addressed the infrastructure, general regulations on RAI therapy, adherence to recommendations, RAI dose selection, factors to elevate RAI dose, and follow-up protocols in DTC patients...
January 29, 2018: Nuclear Medicine Communications
https://www.readbyqxmd.com/read/29380106/simultaneous-detection-of-circulating-and-disseminated-tumor-cells-in-primary-breast-cancer-patients-following-neoadjuvant-chemotherapy
#14
Vincent P Walter, Florin-Andrei Taran, Markus Wallwiener, Markus Hahn, Sara Y Brucker, Andreas D Hartkopf
PURPOSE: Pathological complete response (pCR) is a common endpoint in neoadjuvant chemotherapy (NACT) of primary breast cancer patients (PBC), but does not address the systemic prevalence of minimal residual disease. In this study, we compared pCR with the detection of circulating (CTC) and disseminated tumor cells (DTC) following NACT, as well as their impact on survival. METHODS: Patients with PBC receiving NACT and consecutive surgery were eligible for this study...
January 27, 2018: Archives of Gynecology and Obstetrics
https://www.readbyqxmd.com/read/29374853/a-high-risk-70-gene-signature-is-not-associated-with-the-detection-of-tumor-cell-dissemination-to-the-bone-marrow
#15
Vincent P Walter, Florin-Andrei Taran, Markus Wallwiener, Christina Walter, Eva-Maria Grischke, Diethelm Wallwiener, Sara Y Brucker, Andreas D Hartkopf
PURPOSE: The 70-gene signature (70-GS) is a prognostic tool, grouping patients in risk groups to assess their need for adjuvant chemotherapy. Tumor cell dissemination to the bone marrow is a marker of minimal residual disease and associated with impaired survival. In this study, we aimed to evaluate whether 70-GS is associated with the presence of disseminated tumor cells (DTCs) in the bone marrow of patients with early breast cancer. METHODS: In patients with hormone receptor-positive HER2-negative early breast cancer, the 70-GS was obtained and the presence of DTCs was immunohistochemically evaluated using cytokeratin staining with the A45-B/B3 antibody...
January 27, 2018: Breast Cancer Research and Treatment
https://www.readbyqxmd.com/read/29373949/effect-of-tumor-size-on-risk-of-metastatic-disease-and-survival-for-thyroid-cancer-implications-for-biopsy-guidelines
#16
Xuan V Nguyen, Kingshuk Roy Choudhury, Franklin N Tessler, Jenny K Hoang
<b>Background: </b>In many risk-stratification systems, the decision to biopsy thyroid nodules is determined by their sonographic features and size. Nevertheless, even small, low-suspicion nodules are often biopsied because it is assumed that larger malignant nodules are associated with poorer outcomes. The aim of this study was to quantify the effect of thyroid cancer tumor size on survival and risk of T4 stage, nodal disease, and distant metastases. <b>Methods: </b>The Surveillance, Epidemiology, and End Results (SEER) 18 database was queried to obtain tumor size, staging information, and survival data for cases of differentiated thyroid cancer (DTC) and non-differentiated thyroid cancer reported between 2004 and 2014...
January 26, 2018: Thyroid: Official Journal of the American Thyroid Association
https://www.readbyqxmd.com/read/29363268/synthesis-of-two-electron-bimetallic-cu-ag-and-cu-au-clusters-by-using-cu13-s2cnnbu2-6-c%C3%A2-cph-4-as-a-template
#17
Rhone P Brocha Silalahi, Kiran Kumarvarma Chakrahari, Jian-Hong Liao, Samia Kahlal, Yu-Chiao Liu, Ming-Hsi Chiang, Jean-Yves Saillard, Chen-Wei Liu
Atomically precise Cu-rich bimetallic clusters have been synthesized by adopting a galvanic exchange strategy. [Cu@Cu12(S2CNnBu2)6(C≡CPh)4]+ (1) was used as a template to generate compositionally uniform clusters [M@Cu12(S2CNnBu2)6 (C≡CPh)4]+, where M = Ag (2), Au (3). Structures of 1, 2 and 3 were determined by single crystal X-ray diffraction and the results were supported by ESI-mass spectrometry. The anatomies of clusters 1-3 are very similar, with a centred cuboctahedral cationic core that is surrounded by six di-butyldithiocarbamate (dtc) and four phenylacetylide ligands...
January 24, 2018: Chemistry, An Asian Journal
https://www.readbyqxmd.com/read/29362205/testimonials-and-informational-videos-on-branded-prescription-drug-websites-experimental-study-to-assess-influence-on-consumer-knowledge-and-perceptions
#18
Helen W Sullivan, Amie C O'Donoghue, Jennifer Gard Read, Jacqueline B Amoozegar, Kathryn J Aikin, Douglas J Rupert
BACKGROUND: Direct-to-consumer (DTC) promotion of prescription drugs can affect consumer behaviors and health outcomes, and Internet drug promotion is growing rapidly. Branded drug websites often capitalize on the multimedia capabilities of the Internet by using videos to emphasize drug benefits and characteristics. However, it is unknown how such videos affect consumer processing of drug information. OBJECTIVE: This study aimed to examine how videos on prescription drug websites, and the inclusion of risk information in those videos, influence consumer knowledge and perceptions...
January 23, 2018: Journal of Medical Internet Research
https://www.readbyqxmd.com/read/29350109/tertiary-care-experience-of-sorafenib-in-the-treatment-of-progressive-radioiodine-refractory-differentiated-thyroid-carcinoma-a-korean-multicenter-study
#19
Mijin Kim, Tae Hyuk Kim, Dong Yeob Shin, Dong-Jun Lim, Eui Young Kim, Won Bae Kim, Jae Hoon Chung, YoungKee Shong, Bo Hyun Kim, Won Gu Kim
BACKGROUND: Sorafenib, a multi-kinase inhibitor, is approved for the treatment of patients with radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC). In this study, we evaluated the efficacy and safety of sorafenib in real-world clinical practice and compared the results with those of the DECISION trial. We also evaluated the clinical features associated with better clinical outcomes after sorafenib treatment. METHODS: This multicenter, retrospective cohort study evaluated 98 patients with progressive RAI-refractory DTC who were treated with sorafenib in six tertiary hospitals in Korea...
January 19, 2018: Thyroid: Official Journal of the American Thyroid Association
https://www.readbyqxmd.com/read/29348477/thyroid-cancer-balancing-benefit-and-risk-in-tsh-management-of-dtc
#20
Frederik A Verburg, Markus Luster
No abstract text is available yet for this article.
January 19, 2018: Nature Reviews. Endocrinology
keyword
keyword
45325
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"